BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 20, 2002
View Archived Issues
Novel COX-2 inhibitors in early development at GSK
Read More
Tachykinin antagonists for use in depression and other disorders
Read More
Synthesis of novel 5-HT2A receptor ligands reported at Medicinal Chemistry Symposium
Read More
Abbott identifies aryl tetrahydropyridine farnesyltransferase inhibitors
Read More
Biological activity of paclitaxel-glucose conjugate tested in human cancer cell lines
Read More
Discovery of CCR3 receptor antagonists with potential in allergic asthma
Read More
Novel antiinflammatory agents from Celgene act by inhibiting transcriptional activation in T-cells
Read More
A wealth of data on lumiracoxib presented at the EULAR congress
Read More
NN-2211 may be useful for treating obesity and type 2 diabetes
Read More
Preclinical findings reported for aldose reductase inhibitor fidarestat
Read More
New data on ragaglitazar discussed at the ADA scientific sessions
Read More
Lead PTP1B inhibitor with blood glucose-lowering effects identified by Korean group
Read More
Hydroxamate-based antibiotics targeting LpxC in Gram-negative bacteria
Read More
DISC-GMCSF completes phase I study
Read More
NDA filing for Purdue's abuse-resistant pain medication delayed
Read More
FSME-IMMUN vaccine approved for adult use in Germany
Read More
Chiron grants nonexclusive HCV license to Merck & Co.
Read More
Argenta Discovery and Amedis enter drug discovery collaboration
Read More
Immtech's lead hepatitis C compounds to be validated for further development
Read More
Trospium completes phase III trial in overactive bladder
Read More
CoFactor phase II trial design finalized
Read More
Asthma drug candidate selected under Texas Biotechnology/Schering-Plough collaboration
Read More
Frova launched in U.S.
Read More
Human 5-HT2C receptor ligands selected for further evaluation at Vernalis for use in obesity
Read More
Sankyo patents new antitumor compounds
Read More
3-Dimensional presents new trypsin-like protease inhibitors in recent patent
Read More
Potent inhibitors of IL-12 production and potential therapeutic applications
Read More
Mast cell stabilizers synthesized at Alcon active in model of allergic conjunctivitis
Read More